PHARMEPA Trademark

Trademark Overview

On Thursday, September 14, 2023, a trademark application was filed for PHARMEPA with the United States Patent and Trademark Office. The USPTO has given the PHARMEPA trademark a serial number of 79382234. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2024. This trademark is owned by Igennus Ltd. The PHARMEPA trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements, alternative medicines, namely, natural supplements for treating depression, cardiovascular and anxiety, all containing EPA
pharmepa

General Information

Serial Number79382234
Word MarkPHARMEPA
Filing DateThursday, September 14, 2023
Status700 - REGISTERED
Status DateTuesday, October 29, 2024
Registration Number7546907
Registration DateTuesday, October 29, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements

Goods and ServicesNutritional supplements, alternative medicines, namely, natural supplements for treating depression, cardiovascular and anxiety, all containing EPA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIgennus Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameIgennus Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameIgennus Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 6, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 11, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, May 8, 2024ASSIGNED TO EXAMINER
Friday, May 31, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 25, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 25, 2024REFUSAL PROCESSED BY MPU
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 15, 2024REFUSAL PROCESSED BY IB
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 29, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 31, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, March 31, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 2, 2025FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 29, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, April 19, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 19, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 2, 2025FINAL DISPOSITION PROCESSED

Related Keywords

pharmepa supplements depression cardiovascular containing treating anxiety natural alternative medicines namely